AMGEN

• Sitemap
• Search
• Privacy & Terms
• Contact Us

• RANKL Inhibition
• Publications & Slides
• Resources

The science of

bone biology.

This site provides clinicians with the latest insights about the osteoprotegenin (OPG)/ receptor activator of nuclear factor RB (RANK)/RANK Ligand regulator axis and its roll across a broad range of diseases--such as osteoporosis, treatment-induced bone l

• / Understanding cancer treatment-induced bone loss
• / The role of RANKL in osteoporosis
• / Take our survey now